Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
Mads Halbirk, Henrik Wiggers(Aarhus University Hospital), Helene Nørrelund(Regionshospitalet Viborg), Niels Møller(Aarhus University Hospital), Roni Nielsen(Aarhus University), Hans Eiskjær(Aarhus University Hospital), Jens J. Holst(University of Copenhagen), Torsten Toftegaard Nielsen, Søren Steen Nielsen(Aarhus University Hospital), Hans Erik Bøtker(Aarhus University), Ole Schmitz, Jens Erik Nielsen‐Kudsk(Hôpital Européen Georges-Pompidou)
American Journal of Physiology-Heart and Circulatory Physiology
January 16, 2010
Cited by 165
Related Papers
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
|New England Journal of Medicine|2016|1.7k
Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease
|Journal of the American College of Cardiology|2014|1.5k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|714